Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma

by Elizabeth A. Kuczynski, Robert S. Kerbel
Published 2016-11-01

Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity

by Sophie Langdon, Adina Hughes, Molly A. Taylor, Elizabeth A. Kuczynski, Deanna A. Mele, Oona Delpuech, Laura Jarvis, Anna Staniszewska, Sabina Cosulich, Larissa S. Carnevalli, Charles Sinclair
Published 2018-08-01